Urothelial Cancer
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients With Advanced or Metastatic Urothelial Carcinoma (516-003)
- Details
ClinicalTrials.gov ID:
NCT03606174
Diagnosis Type:
NA
USOR Number:
- Address
910 E Houston St, Suite 100
Tyler, TX 75702
P: (903) 579-9800